Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-03 Sale |
2024-06-05 5:05 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $19.29 | $96,440 | 313,306 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-02 9:07 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $20.15 | $100,750 | 318,306 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 6:55 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $24.38 | $121,913 | 323,306 (Indirect Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:45 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
723 | $28.33 | $20,483 | 77,692 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:44 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
724 | $28.33 | $20,511 | 49,630 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:43 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,969 | $28.33 | $55,782 | 589,447 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:42 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
651 | $28.33 | $18,443 | 328,306 (Indirect Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:42 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
619 | $28.33 | $17,536 | 182,558 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 8:14 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
75,000 | $32.87 | $2,465,063 | 845,811 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 8:13 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,646 | $35.49 | $732,727 | 167,941 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 8:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $24 | $129,936 | 288,195 (Indirect Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:49 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
597 | $20.76 | $12,394 | 77,910 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:40 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
611 | $20.76 | $12,684 | 50,354 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:39 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
543 | $20.76 | $11,273 | 245,131 (Indirect Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:37 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,628 | $20.76 | $33,797 | 550,911 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:29 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
514 | $20.76 | $10,671 | 182,672 (Direct) |
View |
| 2023-12-08 Purchase |
2023-12-11 9:06 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
100,000 | $19.83 | $1,982,940 | 802,168 (Indirect Direct) |
View |
| 2023-12-07 Sale |
2023-12-11 8:59 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
26,978 | $20.02 | $539,969 | 1,031,224 (Direct) |
View |
| 2023-11-30 Purchase |
2023-12-05 08:37 am |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
100,000 | $16.95 | $1,694,565 | 702,168 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-21 5:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
30,000 | $14.68 | $440,259 | 213,177 (Indirect Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 8:41 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $47.91 | $1,197,827 | 500,998 (Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 8:33 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $51.1 | $25,039 | 329,908 (Indirect Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:36 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,682 | $50.34 | $84,672 | 460,998 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:31 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
632 | $50.34 | $31,815 | 18,468 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-08 Option Award |
2024-06-11 5:29 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:28 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:25 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:24 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:22 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:20 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-05-01 7:36 pm |
N/A 2034-04-28 |
Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:14 pm |
N/A 2029-06-18 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
75,000 | $0 | 845,811 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
17,267 | $21.1 | 845,811 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
57,733 | $16 | 845,811 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,646 | $21.09 | 167,941 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:13 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,646 | $0 | 167,941 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 8:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $6.36 | 167,941 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:16 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
83,321 | $0 | 328,957 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:16 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
83,321 | $0.615 | 328,957 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-03 5:00 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0 | 615,449 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-03 5:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0.615 | 615,449 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 8:30 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $0 | 288,195 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 8:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $6.36 | 288,195 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
178,734 | $0 | 197,202 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
178,734 | $0 | 391,911 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:38 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
178,734 | $0 | 329,423 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:35 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks |
102,134 | $0 | 102,134 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:26 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
178,734 | $0 | 224,744 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 8:59 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
26,978 | $0 | 1,031,224 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 8:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
26,978 | $6.36 | 1,031,224 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-11 8:59 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
503,477 | $0 | 1,031,224 (Direct) |
View |
| 2023-11-09 Option Award |
2023-11-13 5:37 pm |
N/A 2033-11-08 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
83,400 | $0 | 83,400 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:41 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 500,998 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:41 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 500,998 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:33 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $0 | 329,908 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:33 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $21.1 | 329,908 (Direct) |
View |